Research Use Only - Not for human consumption. 18+ only.
Clinical TrialsCardiovascular HealthSubcutaneous

Venoruton

Also known as: Rutoside, Hydroxyethylrutosid

A flavonoid-derived peptide compound that improves venous tone and microcirculation through endothelial function enhancement.

Research Status

Clinical Trials

Clinical trials

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Improves venous tone and elasticity
Enhances microcirculation and blood flow
Reduces capillary fragility
Supports endothelial function
May reduce symptoms of chronic venous insufficiency
Promotes lymphatic drainage

Side Effects

Gastrointestinal upset (nausea, mild dyspepsia)
UncommonMild

More common with oral formulations. Taking with food may reduce incidence. Typically resolves within 1-2 weeks of continued use.

Headache
RareMild

Reported in clinical trials at rates <1%. Usually self-resolving.

Dizziness or lightheadedness
RareMild

Rare in clinical populations. May occur if injected too rapidly or in sensitive individuals.

Allergic reaction (rash, itching, angioedema)
RareModerate

Possible in individuals with sensitivity to flavonoids or rutin. Discontinue immediately and seek medical attention if angioedema develops.

Local injection site reactions (redness, swelling, bruising)
UncommonMild

More likely with injectable forms. Rotate injection sites to minimise. Apply ice if swelling occurs.

Flushing or facial redness
RareMild

Transient vasodilatory effect. Typically resolves within minutes to hours.

Dosing Reference

ParameterValue
Dose range250-500 mg
Frequency2-3x daily
TimingWith meals to improve absorption
RouteSubcutaneous

Clinical trials typically used 500mg twice daily. For research purposes only. Dosing based on oral formulations; injectable forms may differ.

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2–8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Venoruton is a flavonoid-derived compound that enhances venous tone and microcirculation by strengthening endothelial function and reducing capillary fragility. It works by stabilising the vascular wall, improving blood vessel elasticity, and promoting lymphatic drainage. These mechanisms help restore normal venous function and reduce symptoms associated with chronic venous insufficiency.

Endothelial Function Enhancement

Venoruton improves endothelial cell integrity and reduces vascular permeability, which strengthens the blood vessel barrier and reduces fluid leakage into surrounding tissues.

Capillary Stabilisation

The compound reduces capillary fragility by reinforcing the structural integrity of capillary walls, decreasing bleeding and improving microcirculatory efficiency.

Venous Tone Improvement

Venoruton enhances smooth muscle contractility in venous walls, improving the ability of veins to maintain tone and prevent blood pooling in the lower extremities.

Anti-inflammatory and Antioxidant Activity

Flavonoid compounds reduce oxidative stress and inflammatory markers in vascular tissue, protecting endothelial cells from damage and supporting long-term vascular health.

  • Venoruton is a semi-synthetic flavonoid derived from rutin, a naturally occurring bioflavonoid
  • Clinical efficacy is primarily documented for oral administration; injectable forms are less common in published literature
  • Effects on microcirculation are measurable within 2-4 weeks of consistent use
  • The compound has a favourable safety profile with minimal systemic side effects in clinical trials

Track your Venoruton research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Venoruton is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.